Striatal NTS1, dopamine D2 and NMDA receptor regulation of pallidal GABA and glutamate release – a dual‐probe microdialysis study in the intranigral 6‐hydroxydopamine unilaterally lesioned rat

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Neuroscience

• Publication date

  2012-01-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1111/j.1460-9568.2011.07949.xPMID 22211865
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of Methamphetamine Self-Administration on Neurotensin Systems of the Basal Ganglia

  2011cited by this paper
• Neurotensin regulates cortical glutamate transmission by modulating N‐methyl‐D‐aspartate receptor functional activity: An in vivo microdialysis study

  2011cited by this paper
• Hyperactivity of the dopaminergic system in NTS1 and NTS2 null mice.

  2010cited by this paper
• The changing world of G protein-coupled receptors: from monomers to dimers and receptor mosaics with allosteric receptor–receptor interactions

  2010cited by this paper
• Emerging evidence for neurotensin receptor 1 antagonists as novel pharmaceutics in neurodegenerative disorders.

  2009cited by this paper
• Electrophysiological Effects of Neurotensin on Globus Pallidus Neurons of 6-Hydroxydopamine-Lesioned Rats

  2009cited by this paper
• Neurochemical changes in the striatum of dyskinetic rats after administration of the cannabinoid agonist WIN55,212-2.

  2009cited by this paper
• Neurotensin receptors as modulators of glutamatergic transmission.

  2008cited by this paper
• Neurotensin receptor involvement in the rise of extracellular glutamate levels and apoptotic nerve cell death in primary cortical cultures after oxygen and glucose deprivation.

  2008cited by this paper
• Biology of Neurotensin: Revisited Study

  2008cited by this paper
• Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment.

  2007cited by this paper
• D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum

  2007cited by this paper
• NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways

  2007influential reference
• Experimental studies and theoretical aspects on A2A/D2 receptor interactions in a model of Parkinson's disease. Relevance for L-dopa induced dyskinesias.

  2006cited by this paper
• Receptor–receptor interactions as studied with microdialysis. Focus on NTR/D2 interactions in the basal ganglia

  2006cited by this paper
• Effects of Systemic Administration of Iptakalim on Extracellular Neurotransmitter Levels in the Striatum of Unilateral 6-Hydroxydopamine-Lesioned Rats

  2006cited by this paper
• Bioactive analogs of neurotensin: focus on CNS effects.

  2006cited by this paper
• The role of neurotensin in central nervous system pathophysiology: what is the evidence?

  2006cited by this paper
• Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine

  2005cited by this paper
• Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity.

  2004cited by this paper
• Neurotensin Receptor Antagonist SR 142948A Alters Fos Expression and Extrapyramidal Side Effect Profile of Typical and Atypical Antipsychotic Drugs

  2004cited by this paper
• Neurotensin: dual roles in psychostimulant and antipsychotic drug responses.

  2003cited by this paper
• The effect of 6‐hydroxydopamine lesions on the release of amino acids in the direct and indirect pathways of the basal ganglia: a dual microdialysis probe analysis

  2003cited by this paper
• Dipeptide Analog of Neurotensin Active Site Prevents the Development of Experimental Parkinson's Syndrome in Mice

  2003cited by this paper
• Convergent evidence from microdialysis and presynaptic immunolabeling for the regulation of γ‐aminobutyric acid release in the globus pallidus following acute clozapine or haloperidol administration in rats

  2002cited by this paper
• MK801 suppresses the L-DOPA-induced increase of glutamate in striatum of hemi-Parkinson rats.

  2002cited by this paper
• d‐amphetamine‐induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors

  2002cited by this paper
• Striatal dopamine–NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors

  2002cited by this paper
• Neurotensin enhances glutamate excitotoxicity in mesencephalic neurons in primary culture

  2002cited by this paper
• Neurotensin-induced modulation of dopamine D2 receptors and their function in rat striatum: Counteraction by a NTR1-like receptor antagonist

  2002cited by this paper
• Neurotensin-deficient mice show altered responses to antipsychotic drugs

  2001cited by this paper
• Antiparkinson-like effects of a novel neurotensin analog in unilaterally 6-hydroxydopamine lesioned rats.

  2001cited by this paper
• The neurotensin antagonist SR 48692 attenuates haloperidol-induced striatal Fos expression in the rat.

  2001cited by this paper
• Nigral neurotensin receptor regulation of nigral glutamate and nigroventral thalamic GABA transmission: a dual-probe microdialysis study in intact conscious rat brain.

  2001cited by this paper
• Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons.

  2001cited by this paper
• Neurotensin and dopamine interactions.

  2001cited by this paper
• The effects of glutamate receptor agonists on neurotensin release using in vivo microdialysis.

  2001cited by this paper
• Systemic administration of adenosine A(2A) receptor antagonist reverses increased GABA release in the globus pallidus of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.

  2000cited by this paper
• Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats

  2000cited by this paper
• Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease.

  2000cited by this paper
• Distribution of the neurotensin receptor NTS1 in the rat CNS studied using an amino-terminal directed antibody.

  2000cited by this paper
• [Functional anatomy of the basal ganglia].

  2000cited by this paper
• Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.

  1999cited by this paper
• Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion.

  1999cited by this paper
• Neurotensin and neurotensin receptors.

  1999cited by this paper
• Dopamine D-1 regulation of caudate neurotensin mRNA in the presence or absence of the nigrostriatal dopamine pathway.

  1999cited by this paper
• Alteration of neurotensin receptors in MPTP-treated mice.

  1999cited by this paper
• Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

  1999cited by this paper
• Neurotensin receptors and dopamine transporters: Effects of MPTP lesioning and chronic dopaminergic treatments in monkeys

  1999cited by this paper
• Widespread expression in adult rat forebrain of mRNA encoding high‐affinity neurotensin receptor

  1998cited by this paper
• The Striatal Neurotensin Receptor Modulates Striatal and Pallidal Glutamate and GABA Release: Functional Evidence for a Pallidal Glutamate–GABA Interaction via the Pallidal–Subthalamic Nucleus Loop

  1998cited by this paper
• Correlative Ultrastructural Distribution of Neurotensin Receptor Proteins and Binding Sites in the Rat Substantia Nigra

  1998cited by this paper
• Differential Effects of lntrastriatal Neurotensin(1–13) and Neurotensin(8–13) on Striatal Dopamine and Pallidal GABA Release. A Dual‐probe Microdialysis Study in the Awake Rat

  1997cited by this paper
• The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments.

  1996influential reference
• Molecular cloning of a levocabastine‐sensitive neurotensin binding site

  1996influential reference
• Dopamine D2-receptors regulate neurotensin release from nucleus accumbens and striatum as measured by in vivo microdialysis.

  1996cited by this paper
• Cellular distribution of neurotensin receptors in rat brain: Immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor

  1996cited by this paper
• Morphologically distinct subpopulations of neurotensin-immunoreactive striatal neurons observed in rat following dopamine depletions and D2 receptor blockade project to the globus pallidus.

  1996cited by this paper
• Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits.

  1995cited by this paper
• Neurotensin increases endogenous glutamate release in the neostriatum of the awake rat

  1995cited by this paper
• Receptor‐Receptor Interactions and Their Relevance for Receptor Diversity

  1995cited by this paper
• Release of Glutamate and Aspartate from CA1 Synaptosomes: Selective Modulation of Aspartate Release by Ionotropic Glutamate Receptor Ligands

  1995cited by this paper
• Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop.

  1995cited by this paper
• C-fos mediates antipsychotic-induced neurotensin gene expression in the rodent striatum.

  1995cited by this paper
• Facilitation of GABA release by neurotensin is associated with a reduction of dopamine release in rat nucleus accumbens.

  1994cited by this paper
• Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study

  1994cited by this paper
• Glutamate receptors in striatum and substantia nigra: effects of medial forebrain bundle lesions.

  1994cited by this paper
• Coexpression of neurotensin and c-fos mRNAs in rat neostriatal neurons following acute haloperidol.

  1994cited by this paper
• The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain

  1993cited by this paper
• Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin.

  1992cited by this paper
• Neuropeptides, excitatory amino acid and adenosine A2 receptors regulate D2 receptors via intramembrane receptor-receptor interactions. Relevance for Parkinson's disease and schizophrenia.

  1992cited by this paper
• Mesencephalic dopaminergic neurons in primary cultures express functional neurotensin receptors

  1992cited by this paper
• Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum.

  1992cited by this paper
• Effects of a unilateral 6-hydroxydopamine lesion and prolonged L-3,4-dihydroxyphenylalanine treatment on peptidergic systems in rat basal ganglia.

  1992cited by this paper
• The intrastriatal 6-hydroxydopamine model of hemiparkinsonism: quantitative receptor autoradiographic evidence of correlation between circling behavior and presynaptic as well as postsynaptic nigrostriatal markers in the rat.

  1992cited by this paper
• Functional architecture of basal ganglia circuits: neural substrates of parallel processing.

  1990cited by this paper
• Localization of N‐Methyl‐d‐Aspartate Receptors in the Rat Striatum: Effects of Specific Lesions on the [3H]3‐(2‐Carboxypiperazin‐4‐yl)propyl‐1‐Phosphonic Acid Binding

  1990cited by this paper
• The effects of intranigral GABA and dynorphin A injections on striatal dopamine and GABA release: evidence that dopamine provides inhibitory regulation of striatal GABA neurons via D2 receptors.

  1990cited by this paper
• Disinhibition as a basic process in the expression of striatal functions.

  1990cited by this paper
• Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia.

  1990cited by this paper
• Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene.

  1989cited by this paper
• The functional anatomy of basal ganglia disorders.

  1989cited by this paper
• Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum.

  1989cited by this paper
• Asymmetrical distribution of neurotensin immunoreactivity following unilateral injection of 6-hydroxydopamine in rat ventral tegmental area (VTA).

  1989cited by this paper
• Correspondence between high affinity 125I‐neurotensin binding sites and dopaminergic neurons in the rat substantia nigra and ventral tegmental area: A combined radioautographic and immunohistochemical light microscopic study

  1989cited by this paper
• Stimulation of GABA release from the rat neostriatum and globus pallidus in vivo by corticotropin-releasing factor.

  1989cited by this paper
• The catalepsy test: its ups and downs.

  1988cited by this paper
• Dopaminergic control of 125I-labeled neurotensin binding site density in corticolimbic structures of the rat brain.

  1986cited by this paper
• Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis.

  1986cited by this paper
• Comparative localization of neurotensin receptors on nigrostriatal and mesolimbic dopaminergic terminals.

  1985cited by this paper
• Neurotensin-dopamine interactions in the CNS

  1985cited by this paper
• Neurotensin in vitro markedly reduces the affinity in subcortical limbic 3H-N-propylnorapomorphine binding sites.

  1983cited by this paper
• The rat brain in stereotaxic coordinates: Authors: George Paxinos & Charles Watson Academic Press Australia, 1982 Softback, 154 pages (including 71 plates), 35.00 Aust $

  1983influential reference
• On the functional role of coexistence of 5-HT and substance P in bulbospinal 5-HT neurons. Substance P reduces affinity and increases density of 3H-5-HT binding sites.

  1983cited by this paper
• Isolation of a tridecapeptide from bovine intestinal tissue and its partial characterization as neurotensin.

  1976cited by this paper
• The isolation of a new hypotensive peptide, neurotensin, from bovine hypothalami.

  1973cited by this paper
• Morphine catalepsy in the rat: relation to striatal dopamine metabolism.

  1972cited by this paper
• Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

  1970cited by this paper

• Neurotensin modulation of inflammation: an update

  2023cites this paper
• Acute administration of a dopamine D2/D3 receptor agonist alters behavioral and neural parameters in adult zebrafish

  2022cites this paper
• Dopaminergic and nitric oxide systems interact to regulate the electrical activity of neurons in the medial septal nucleus in rats

  2022cites this paper
• Acute cocaine treatment enhances the antagonistic allosteric adenosine A2A-dopamine D2 receptor–receptor interactions in rat dorsal striatum without increasing significantly extracellular dopamine levels

  2020cites this paper
• The globus pallidus as a target for neuropeptides and endocannabinoids participating in central activities.

  2019cites this paper
• Brain Dopamine Transmission in Health and Parkinson's Disease: Modulation of Synaptic Transmission and Plasticity Through Volume Transmission and Dopamine Heteroreceptors

  2018cites this paper
• In Vivo Microdialysis Technique Applications to Understand the Contribution of Receptor–Receptor Interactions to the Central Nervous System Signaling

  2018cites this paper
• Understanding the Role of GPCR Heteroreceptor Complexes in Modulating the Brain Networks in Health and Disease

  2017cites this paper
• Functional role of striatal A2A, D2, and mGlu5 receptor interactions in regulating striatopallidal GABA neuronal transmission

  2016cites this paper
• Presynaptic D1 heteroreceptors and mGlu autoreceptors act at individual cortical release sites to modify glutamate release.

  2016cites this paper
• Antidepressant effect of pramipexole in mice forced swimming test: A cross talk between dopamine receptor and NMDA/nitric oxide/cGMP pathway.

  2016cites this paper
• Synthetic cannabinoid JWH-018 and its halogenated derivatives JWH-018-Cl and JWH-018-Br impair Novel Object Recognition in mice: Behavioral, electrophysiological and neurochemical evidence.

  2016influential citation
• Loss of the preferential control over the striato-nigral direct pathway by striatal NMDA receptors in a rat model of Parkinson's disease.

  2015cites this paper
• Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats.

  2014cites this paper
• Neurotensin NTS1-dopamine D2 receptor-receptor interactions in putative receptor heteromers: relevance for Parkinson's disease and schizophrenia.

  2014cites this paper
• Gut-brain peptides in corticostriatal-limbic circuitry and alcohol use disorders

  2014cites this paper
• Diverse Roles of Neurotensin Agonists in the Central Nervous System

  2013cites this paper
• Extrasynaptic Neurotransmission in the Modulation of Brain Function. Focus on the Striatal Neuronal–Glial Networks

  2012cites this paper
• Interactions between NMDA and dopamine receptors: a potential therapeutic target.

  2012cites this paper